Disease | gastroesophageal reflux disease |
Phenotype | C0039446|telangiectasias |
Sentences | 1 |
PubMedID- 23492605 | Methods: the treatment regimen provides for initial treatment of type a telangiectasias with just conventional reflux sclerotherapy, followed three weeks later by treatment of type b telangiectasias with 0.25-0.5% polidocanol foam, associated with both external compression and tumescent vasoconstriction (start technique). |
Page: 1